2017
DOI: 10.1016/j.biochi.2017.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(38 citation statements)
references
References 55 publications
0
36
0
2
Order By: Relevance
“…Taken together, these findings suggest that the identified miRNA-targeted genes contribute to regulating genes and pathways that are involved in adipogenesis, which may help to define the fat deposition differences between two groups of pigs. Recently, it has been shown that targeting PPARs is a potential way to treat NAFLDs [63,64]. Since the miRNAs that we uncovered in our study regulate the PPAR pathway, this study helps us understand the players involved in the regulation of this pathway and could provide insights into better treatment for NAFLDs.…”
Section: Discussionmentioning
confidence: 63%
“…Taken together, these findings suggest that the identified miRNA-targeted genes contribute to regulating genes and pathways that are involved in adipogenesis, which may help to define the fat deposition differences between two groups of pigs. Recently, it has been shown that targeting PPARs is a potential way to treat NAFLDs [63,64]. Since the miRNAs that we uncovered in our study regulate the PPAR pathway, this study helps us understand the players involved in the regulation of this pathway and could provide insights into better treatment for NAFLDs.…”
Section: Discussionmentioning
confidence: 63%
“…Fragments of liver tissue (1 mm 3 ) were fixed in 2.5 % glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for 2 h at room temperature [32]. HepG2 cells were collected and prepared as described previously [30].…”
Section: Transmission Electron Microscopymentioning
confidence: 99%
“…However, their precise mechanism of action is not yet completely understood (Martin, Schoonjans, Lefebvre, Staels, & Auwerx, 1997;Schoonjans et al, 1995;Staels et al, 1998). Studies with diet-induced obese (DIO) mice models treated with this class of drugs showed important secondaries effects on preventing mass body gain, reducing fat stores, and improving insulin sensitivity as a result of decreased plasma fatty acid levels (Fernandes-Santos, Carneiro, de Souza Mendonca, Aguila, & Mandarim-de-Lacerda, 2009;Silva Veiga et al, 2017). Besides skeletal muscle and liver, recent findings suggest that PPARα agonists may also exert important effects on white adipose tissue (WAT) metabolism, playing a relevant role on their secondaries effects as well (Jeong & Yoon, 2009;Rachid et al, 2015).…”
mentioning
confidence: 99%